CorMedix (CRMD) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.
- CorMedix's Income towards Parent Company rose 400227.68% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6252.03% up from last year.
- According to the latest figures from Q3 2025, CorMedix's Income towards Parent Company is $108.6 million, which was up 400227.68% from $19.8 million recorded in Q2 2025.
- CorMedix's Income towards Parent Company's 5-year high stood at $108.6 million during Q3 2025, with a 5-year trough of -$14.5 million in Q1 2024.
- In the last 5 years, CorMedix's Income towards Parent Company had a median value of -$7.4 million in 2021 and averaged $2.3 million.
- As far as peak fluctuations go, CorMedix's Income towards Parent Company plummeted by 6414.73% in 2022, and later soared by 400227.68% in 2025.
- Quarter analysis of 5 years shows CorMedix's Income towards Parent Company stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then dropped by 18.7% to -$9.7 million in 2023, then skyrocketed by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
- Its Income towards Parent Company was $108.6 million in Q3 2025, compared to $19.8 million in Q2 2025 and $20.6 million in Q1 2025.